Catalent
CTLT
#1584
Rank
S$14.45 B
Marketcap
$79.63
Share price
0.26%
Change (1 day)
77.04%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Revenue for Catalent (CTLT)

Revenue in 2024 (TTM): S$5.90 Billion

According to Catalent's latest financial reports the company's current revenue (TTM ) is S$5.88 Billion. In 2023 the company made a revenue of S$5.41 Billion a decrease over the revenue in the year 2022 that were of S$6.37 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Catalent from 2013 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) S$5.90 B9.15%
2023 S$5.41 B-15.13%
2022 S$6.37 B5.22%
2021 S$6.06 B32.21%
2020 S$4.58 B24.59%
2019 S$3.67 B8.26%
2018 S$3.39 B10.51%
2017 S$3.07 B12.08%
2016 S$2.74 B5.75%
2015 S$2.59 B6.35%
2014 S$2.44 B6.58%
2013 S$2.28 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
S$0.84 B-85.62%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.28 B-95.12%๐Ÿ‡บ๐Ÿ‡ธ USA
S$5.24 B-10.75%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
S$0.42 B-92.75%๐Ÿ‡บ๐Ÿ‡ธ USA